Heron Therapeutics (HRTX)
NASDAQ:HRTX
Holding HRTX?
Track your performance easily

Heron Therapeutics (HRTX) Ownership - Who Owns Heron Therapeutics?

1,490 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 21, 2023
William Forbes
Evp, Chief Development Officer
xxxxxxxxxxxxx
$27250
Nov 20, 2023
William Forbes
Evp, Chief Development Officer
xxxxxxxxxxxxx
$46500
Nov 17, 2023
Ira Duarte
Evp & Cfo
xxxxxxxxxxxxx
$74800
Nov 17, 2023
Craig Collard
Ceo,director
xxxxxxxxxxxxx
$136500

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,179,198Institution5.39%15,949,436
8,131,678Institution5.36%15,856,772
7,002,620Institution4.62%13,655,109
5,821,098Insider3.84%11,351,141
4,763,837Institution3.14%9,289,482
4,480,430Institution2.95%8,736,839
3,871,949Institution2.55%7,550,301
2,836,482Institution1.87%5,531,140
2,012,442Institution1.33%3,924,262
1,526,230Institution1.01%2,976,149

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,002,620Institution4.62%13,655,109
4,480,430Institution2.95%8,736,839
3,871,949Institution2.55%7,550,301
2,012,442Institution1.33%3,924,262
1,526,230Institution1.01%2,976,149
1,172,936Institution0.77%2,287,225
1,094,589Institution0.72%2,134,449
831,618Institution0.55%1,621,655
727,424Institution0.48%1,418,477
614,746Institution0.41%1,198,755

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,683,800Institution3.09%13,910,886
2,332,717Institution1.54%6,928,169
3,145,020Institution2.07%6,132,789
2,698,557Institution1.78%5,127,258
998,601Institution0.66%1,947,272
460,985Institution0.30%1,369,125
713,867Institution0.47%1,356,347
377,664Institution0.25%1,121,662
283,517Institution0.19%538,682
272,743Institution0.18%531,849

FAQ

Who Owns Heron Therapeutics (HRTX)?
Currently, no data Available
What percentage of Heron Therapeutics (HRTX) stock is held by institutional investors?
Currently, no data Available
What percentage of Heron Therapeutics (HRTX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Heron Therapeutics (HRTX)?
Vanguard owns the most shares of Heron Therapeutics (HRTX).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis